#University of Colorado Cancer Center

The study followed up with people five to seven years after treatment, allowing the researchers to correlate blood factors with survival.

Targeted therapies and immunotherapies may be effective against the bone metastases that grow from primary prostate cancers.

“What the study means, and what we show, is that location or income should not hinder the use of these [drugs].”

Lung cancer is the No. 1 cause of cancer-related death in the U.S. Despite advances in research, there are misconceptions about the disease.

Rural Americans diagnosed with cancer are more likely to die from their conditions than are urban Americans.

“Our goal is to identify risk factors that can predict or mitigate the risk of these people developing second primary cancers.”

A study will evaluate whether counseling helps to lessen symptoms of depression and anxiety and improve quality of life.

The team reasoned that if reducing DNA repair killed some cells, then a dramatically reducing DNA repair could kill even more.

By combining the tools of pathology, computational modeling and genomics, the project hopes to discover and test therapeutic interventions.

The research focuses on natural killer cells, which recognize and attack cells affected by cancer, and genes that help target invaders.

It was generally younger, healthier women who chose to have combined breast and gynecologic surgeries.

Being aware of their BRCA status is associated with better breast cancer outcomes for women who decide against preventive surgery.

The answer may lie in the damage radiation therapy does to the immune system.

“We’re taking what we know from human cancers and applying it in canine cancers.”

Chance and randomness certainly play major roles in deciding which individuals get cancer. But the dice are loaded.

The results from an innovative, “virtual” clinical trial were presented at the 2019 ASCO Annual Meeting.